EGFR and neoplasm: Various kinds of molecular-targeted agents, including biopharmaceutical products such as antigen-specific antibodies have been used to treat colorectal cancers, and epidermal growth factor receptor (EGFR) is one of the major targets of these treatments because >80% of these tumours express EGFR2, 3, 4.